These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20647559)

  • 1. Therapeutic potential of valproic acid for retinitis pigmentosa.
    Clemson CM; Tzekov R; Krebs M; Checchi JM; Bigelow C; Kaushal S
    Br J Ophthalmol; 2011 Jan; 95(1):89-93. PubMed ID: 20647559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
    Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
    Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa.
    Totan Y; Güler E; Yüce A; Dervişogulları MS
    Indian J Ophthalmol; 2017 Oct; 65(10):984-988. PubMed ID: 29044065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral valproic acid in patients with retinitis pigmentosa.
    Kumar A; Midha N; Gogia V; Gupta S; Sehra S; Chohan A
    J Ocul Pharmacol Ther; 2014 Sep; 30(7):580-6. PubMed ID: 24955739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
    Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
    JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
    Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
    Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of central retinal function in patients with advanced retinitis pigmentosa.
    Gerth C; Wright T; Héon E; Westall CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1312-8. PubMed ID: 17325178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study.
    Iraha S; Hirami Y; Ota S; Sunagawa GA; Mandai M; Tanihara H; Takahashi M; Kurimoto Y
    Clin Ophthalmol; 2016; 10():1375-84. PubMed ID: 27536054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the EYS gene account for approximately 5% of autosomal recessive retinitis pigmentosa and cause a fairly homogeneous phenotype.
    Littink KW; van den Born LI; Koenekoop RK; Collin RW; Zonneveld MN; Blokland EA; Khan H; Theelen T; Hoyng CB; Cremers FP; den Hollander AI; Klevering BJ
    Ophthalmology; 2010 Oct; 117(10):2026-33, 2033.e1-7. PubMed ID: 20537394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of scientific rationale for use of valproic acid for retinitis pigmentosa.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Berson EL
    Br J Ophthalmol; 2011 May; 95(5):744. PubMed ID: 21131379
    [No Abstract]   [Full Text] [Related]  

  • 15. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
    Lieb DF; Scott IU; Flynn HW; Miller D; Feuer WJ
    Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term oral valproic Acid on vision and visual field in retinitis pigmentosa.
    Shanmugam PM; Minija CK; Ramanjulu R; Tekwani P; Saxena M
    Ophthalmol Ther; 2012 Dec; 1(1):6. PubMed ID: 25135586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
    Bahrami H; Melia M; Dagnelie G
    BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.